David Reynoso Md Phd An Infectious Disease Specialist With

david Reynoso Md Phd An Infectious Disease Specialist With
david Reynoso Md Phd An Infectious Disease Specialist With

David Reynoso Md Phd An Infectious Disease Specialist With Call (409)266 1888 to schedule. adult infectious diseases, travel medicine. galveston 77555. <p>dr. david reynoso earned his medical degree and doctorate in philosophy at the university of texas medical school at houston. he completed internal medicine residency at baylor college of medicine and a fellowship in infectious diseases at the. Dr. david reynoso earned his medical degree and doctorate in philosophy at the university of texas medical school at houston. he completed internal medicine residency at baylor college of medicine and a fellowship in infectious diseases at the university of texas medical branch (utmb) in galveston. he joined the faculty at the university of.

Dr david reynoso md вђ Galveston Tx Internal Medicine
Dr david reynoso md вђ Galveston Tx Internal Medicine

Dr David Reynoso Md вђ Galveston Tx Internal Medicine I am an infectious diseases clinician with research background in cancer biology, transmissible diseases, and molecular biology. david reynoso; md, phd. contact. connect with experts in. David reynoso m.d., ph.d. npi 1205198405 internal medicine infectious disease in galveston, tx quality rating: 91.2 out of 100 score npi status: active since june 13, 2012. Dr david reynoso, md, phd is a medicare enrolled "internal medicine infectious disease" physician in galveston, texas. he went to university of texas medical school at houston and graduated in 2012 and has 12 years of diverse experience with area of expertise as infectious disease. Infectious disease medicine* • male • age 42. dr. david reynoso, md is an infectious disease internist in galveston, tx and has over 11 years of experience in the medical field. he graduated from university of texas health san antonio school of dentistry in 2012. he is affiliated with utmb health galveston campus. he is not accepting new.

Comments are closed.